The observed LEP upregulation in the OBS treatment group aligns with evidence suggesting that folic acid influences lipid metabolism, insulin sensitivity, and inflammatory pathways in obesity models [43,44]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.